http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114739985-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_246146645c44b223b6a2e9a82d4287a9 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-76 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 |
| filingDate | 2022-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9756d6d5df2c8400c6ba06e8256f7e39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1896af89620e9436efc5d49a5eba9d50 |
| publicationDate | 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114739985-A |
| titleOfInvention | A kind of human extracellular matrix metalloproteinase inducible factor magnetic particle chemiluminescence immunoquantitative detection kit and detection method thereof |
| abstract | The invention discloses a human extracellular matrix metalloproteinase-inducing factor magnetic particle chemiluminescence immunoquantitative detection kit and a detection method, wherein the kit comprises streptavidin-coated magnetic particle suspension, alkaline phosphatase Labeled human extracellular matrix metalloproteinase-inducing factor CD147 monoclonal antibody, biotin-labeled human extracellular matrix metalloproteinase-inducing factor CD147 monoclonal antibody, the kit combines the antigen of the test sample with biotin-labeled CD147 monoclonal antibody , Alkaline phosphatase-labeled CD147 monoclonal antibody is coupled to form a complex, and after adding an enzymatic chemiluminescence substrate to the complex, a luminescence reaction is formed to detect the luminescence intensity to detect the human extracellular matrix metalloproteinase-inducing factor in the sample to be tested. concentration. The kit of the invention avoids the shortcomings of the enzyme-linked immunosorbent kit, such as narrow linear range and complicated operation, and solves the defects of low sensitivity, poor stability and high cost. |
| priorityDate | 2022-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 291.